Ttk Healthcare submits unaudited financial results

03 Nov 2023 Evaluate
Ttk Healthcare has informed that it enclosed the Unaudited Financial Results along with the Limited Review Report from the Statutory Auditors of the Company, for the Second Quarter and Half-Year ended 30th September, 2023, duly reviewed by the Audit Committee at their meeting held yesterday on 2nd November, 2023 and approved by the Board of Directors of the Company at their Meeting held today.

The above information is a part of company’s filings submitted to BSE.


TTK Healthcare Share Price

1189.00 -8.10 (-0.68%)
01-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1696.95
Dr. Reddys Lab 1152.40
Cipla 1444.55
Lupin 1956.40
Zydus Lifesciences 877.50
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Please wait your portfolio is updating...